Genus Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.68M Buy
8,230
+2,100
+34% +$685K 0.34% 90
2025
Q1
$1.66M Buy
+6,130
New +$1.66M 0.24% 100
2024
Q4
Hold
0
9